Discussion of research status and hotspot of Zuogui Pills based on CiteSpace visualization software
ZHANG Mingzhao1 LI Xiao2 JU Baojun1 MA Miaomiao1 ZHANG Yongtao1 LI Luyu1 YAO Junchao1 LIU Feng1
1.The First Clinical Medical College, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China; 2.Department of Andrology, the First Affiliated Hospital of Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China
Abstract：Objective To understand the development status and research hotspots of Zuogui Pills by CiteSpace visualization software. Methods The literatures about Zuogui Pills from January 1993 to December 2022 were searched in CNKI, VIP, Wanfang Data, Wanfang Med Oline, and China Biology Medicine Literature Service System. CiteSpace 6.2.R2 software was used to visualize the authors, institutions, keywords, and other information. Results A total of 1 050 relevant literatures were included in the study. In 2017, the number of literatures published on Zuogui Pills was the highest, with 90 articles. There were 76 authors who had published more than five literatures. The institution with the highest number of publications was Liaoning University of Traditional Chinese Medicine. There were ten keywords with frequency ≥19 in the literatures about Zuogui Pills, forming 12 natural clusters, and 25 emergent keywords. Conclusion The clinical application of Zuogui Pills involves a variety of chronic diseases, and the mechanism of action is mostly focused on molecular expression.
张铭钊1 李霄2 琚保军1 马苗苗1 张永涛1 李鲁豫1 姚均超1 刘峰1. 基于CiteSpace可视化软件探讨左归丸的研究现状与研究热点[J]. 中国医药导报, 2023, 20(36): 131-135,141.
ZHANG Mingzhao1 LI Xiao2 JU Baojun1 MA Miaomiao1 ZHANG Yongtao1 LI Luyu1 YAO Junchao1 LIU Feng1. Discussion of research status and hotspot of Zuogui Pills based on CiteSpace visualization software. 中国医药导报, 2023, 20(36): 131-135,141.
2023, Vol. 20 
京公网安备 11010502046598号